Top News
Latest News
RESEARCH
27 Feb 2026
Can AI Crack the Code on Fibrosis?INNOVATION
25 Feb 2026
AI Unlocks the Secret to Cell EntryPARTNERSHIPS
24 Feb 2026
U.S. Peptide Groups Form GMP AllianceINVESTMENT
23 Feb 2026
$305mn Bet on Peptides Signals Shift in Cancer
AI-Designed Peptide Enters Late-Stage Infection Trial
INNOVATION
20 Feb 2026
Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections
RESEARCH
30 Jan 2026
Can Peptide Pills Finally Challenge Cholesterol Injections?
Phase 3 data suggest oral peptide drugs could rival injectables for lowering LDL cholesterol, pointing to a future shift if approvals and ...
PARTNERSHIPS
27 Jan 2026
Peptide Pact Promises a Stronger Supply Chain
Lupin and PolyPeptide join forces to stabilize peptide sourcing as global demand strains supply chains
INVESTMENT
26 Jan 2026
Lilly’s $6B API Bet Fuels a U.S. Peptide Race
Lilly’s Alabama investment shows how peptide capacity and reliable supply are becoming make-or-break advantages for the next wave of drugs
MARKET TRENDS
22 Jan 2026
GLP-1 Drugs Get Cheaper and More Consumer-Friendly
Novo Nordisk and Eli Lilly roll out lower self-pay prices, reflecting a more consumer-oriented GLP-1 market shaped by policy, access, and ...
PARTNERSHIPS
20 Jan 2026
Pfizer Fast-Tracks Obesity Drug Push With $4.9B Metsera Deal
Pfizer’s $4.9B Metsera acquisition boosts its obesity pipeline, adding key drug candidates amid intensifying competition from Novo and pee...
INSIGHTS
19 Jan 2026
AI, Cash, and a Clock Are Redefining Peptide Drug Development
Fresh funding and selective AI use are pushing peptide companies to prove progress earlier and with more discipline
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.